119 related articles for article (PubMed ID: 22708450)
21. Weight reduction versus antihypertensive drug therapy in obese men with high blood pressure: effects upon plasma insulin levels and association with changes in blood pressure and serum lipids.
Fagerberg B; Berglund A; Andersson OK; Berglund G
J Hypertens; 1992 Sep; 10(9):1053-61. PubMed ID: 1328365
[TBL] [Abstract][Full Text] [Related]
22. Quinapril reduces arterial blood pressure and improves metabolic control in elderly hypertensive diabetic patients.
Paolisso G; Gambardella A; Verza M; Varricchio M
Diabete Metab; 1990; 16(3):264-5. PubMed ID: 2210025
[No Abstract] [Full Text] [Related]
23. [Effect of amlodipine on intravascular thrombocyte activity in patients with arterial hypertension and metabolic syndrome].
Medvedev IN; Gromnatskiĭ NI
Klin Med (Mosk); 2005; 83(2):37-40. PubMed ID: 15803830
[TBL] [Abstract][Full Text] [Related]
24. Irbesartan for the treatment of hypertension in patients with the metabolic syndrome: a sub analysis of the Treat to Target post authorization survey. Prospective observational, two armed study in 14,200 patients.
Kintscher U; Bramlage P; Paar WD; Thoenes M; Unger T
Cardiovasc Diabetol; 2007 Apr; 6():12. PubMed ID: 17407587
[TBL] [Abstract][Full Text] [Related]
25. Efficacy and tolerability of rilmenidine compared with isradipine in hypertensive patients with features of metabolic syndrome.
Widimský J; Sirotiaková J
Curr Med Res Opin; 2006 Jul; 22(7):1287-94. PubMed ID: 16834827
[TBL] [Abstract][Full Text] [Related]
26. Association between alcohol intake and metabolic syndrome in patients with hypertension.
Wakabayashi I
Clin Exp Hypertens; 2011; 33(5):299-303. PubMed ID: 21721986
[TBL] [Abstract][Full Text] [Related]
27. Relationship between melatonin secretion and nighttime blood pressure in elderly individuals with and without antihypertensive treatment: a cross-sectional study of the HEIJO-KYO cohort.
Obayashi K; Saeki K; Tone N; Kurumatani N
Hypertens Res; 2014 Oct; 37(10):908-13. PubMed ID: 24849270
[TBL] [Abstract][Full Text] [Related]
28. Potential use of melatonin as adjunct antihypertensive therapy.
Scheer FA
Am J Hypertens; 2005 Dec; 18(12 Pt 1):1619-20. PubMed ID: 16364835
[No Abstract] [Full Text] [Related]
29. The 'pyrrhic victory' of amlodipine over hydrochlorothiazide in the OLAS Study.
Thomopoulos C; Tsioufis C; Makris T; Stefanadis C
J Hum Hypertens; 2011 Jun; 25(6):401-2; author reply 403-4. PubMed ID: 21368776
[No Abstract] [Full Text] [Related]
30. [Stroke and epiphysis].
Arushanian EB; Naumov SS
Zh Nevrol Psikhiatr Im S S Korsakova; 2009; 109(12 Suppl 2):67-74. PubMed ID: 20879108
[TBL] [Abstract][Full Text] [Related]
31. [Effect of moxonidine monotherapy and in combination with melatonin on hemodynamic parameters in patients with arterial hypertension].
Zaslavskaia RM; Komarov FI; Shakirova AN; Teĭblium MM; Akhmetov KZh
Klin Med (Mosk); 2000; 78(4):41-4. PubMed ID: 10833890
[TBL] [Abstract][Full Text] [Related]
32. [Characteristics of carbohydrate metabolism changes in elderly patients with gout and metabolic syndrome].
Kunitskaia NA; Ar'ev AL
Adv Gerontol; 2012; 25(1):90-4. PubMed ID: 22708451
[TBL] [Abstract][Full Text] [Related]
33. [Characteristic of hypertensive subjects with metabolic syndrome and its components in communities].
Lu JX; Bao YQ; Jia WP; Xiang KS
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2006 Dec; 28(6):756-60. PubMed ID: 17260461
[TBL] [Abstract][Full Text] [Related]
34. Olmesartan/amlodipine combination versus olmesartan or amlodipine monotherapies on blood pressure and insulin resistance in a sample of hypertensive patients.
Derosa G; Cicero AF; Carbone A; Querci F; Fogari E; D'Angelo A; Maffioli P
Clin Exp Hypertens; 2013; 35(5):301-7. PubMed ID: 22954201
[TBL] [Abstract][Full Text] [Related]
35. [Time-dependent effects of antihypertensive agents and chronocorrecting action of melatonin in patients with arterial hypertension].
Zaslavskaia RM; Komarov FI; Makarova LA; Shakirova AN; Narmanova OZh; Biiasilov N
Vestn Ross Akad Med Nauk; 2000; (8):36-41. PubMed ID: 11022421
[TBL] [Abstract][Full Text] [Related]
36. Moxonidine in the treatment of overweight and obese patients with the metabolic syndrome: a postmarketing surveillance study.
Sharma AM; Wagner T; Marsalek P
J Hum Hypertens; 2004 Sep; 18(9):669-75. PubMed ID: 15269705
[TBL] [Abstract][Full Text] [Related]
37. Improved insulin sensitivity with the angiotensin II-receptor blocker losartan in patients with hypertension and other cardiovascular risk factors.
Aksnes TA; Reims HM; Guptha S; Moan A; Os I; Kjeldsen SE
J Hum Hypertens; 2006 Nov; 20(11):860-6. PubMed ID: 16988754
[TBL] [Abstract][Full Text] [Related]
38. [Arterial hypertension and insulin resistance].
Miroshnik NIu; Chamontin B; Brillac T; Salvador M; Amar J
Lik Sprava; 1995; (9-12):44-7. PubMed ID: 8983788
[TBL] [Abstract][Full Text] [Related]
39. [Melatonin as a regulator of metabolism].
Dzherieva IS; Volkova NI; Rapoport SI
Klin Med (Mosk); 2012; 90(10):27-30. PubMed ID: 23285758
[TBL] [Abstract][Full Text] [Related]
40. [The influence of antihypertensive agents on plasmatic and vascular-thrombocytic homeostasis in metabolic syndrome].
Vengerovskiĭ AI; Idrisova EM; Bushkova EA; Mananko EI; Krasnova NM
Eksp Klin Farmakol; 2008; 71(6):8-12. PubMed ID: 19140507
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
